APA (7th ed.) Citation

Oshima, M., Jardine, M. J., Agarwal, R., Bakris, G., Cannon, C. P., Charytan, D. M., . . . Heerspink, H. J. L. (2021). Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice. Kidney international, 99(4), 999. https://doi.org/10.1016/j.kint.2020.10.042

Chicago Style (17th ed.) Citation

Oshima, Megumi, et al. "Insights from CREDENCE Trial Indicate an Acute Drop in Estimated Glomerular Filtration Rate During Treatment with Canagliflozin with Implications for Clinical Practice." Kidney International 99, no. 4 (2021): 999. https://doi.org/10.1016/j.kint.2020.10.042.

MLA (9th ed.) Citation

Oshima, Megumi, et al. "Insights from CREDENCE Trial Indicate an Acute Drop in Estimated Glomerular Filtration Rate During Treatment with Canagliflozin with Implications for Clinical Practice." Kidney International, vol. 99, no. 4, 2021, p. 999, https://doi.org/10.1016/j.kint.2020.10.042.